Article Versions Notes

Derakhshani A, Hashemzadeh S, Asadzadeh Z, Shadbad MA, Rasibonab F, Safarpour H, Jafarlou V, Solimando AG, Racanelli V, Singh PK, et al. Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine. Cancers. 2021; 13(10):2414. https://doi.org/10.3390/cancers13102414

Derakhshani, Afshin, Shahryar Hashemzadeh, Zahra Asadzadeh, Mahdi Abdoli Shadbad, Farnaz Rasibonab, Hossein Safarpour, Vahid Jafarlou, Antonio Giovanni Solimando, Vito Racanelli, Pankaj Kumar Singh, and et al. 2021. "Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine" Cancers 13, no. 10: 2414. https://doi.org/10.3390/cancers13102414

Derakhshani, A., Hashemzadeh, S., Asadzadeh, Z., Shadbad, M. A., Rasibonab, F., Safarpour, H., Jafarlou, V., Solimando, A. G., Racanelli, V., Singh, P. K., Najafi, S., Javadrashid, D., Brunetti, O., Silvestris, N., & Baradaran, B. (2021). Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine. Cancers, 13(10), 2414. https://doi.org/10.3390/cancers13102414